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Introduction: Several reports suggest unexpectedly high rates of late abdominal aortic aneurysm (AAA) rupture occur
after endovascular AAA repair (EVAR). However, a population-based study examining causes of late death after EVAR
vs open surgical repair has not been performed.
Methods:We performed a retrospective cohort study of patients undergoing infrarenal AAA repair using information from
the Medicare inpatient hospital discharge records (MedPAR files), physician claim files (Part B files, 20% sample), and
Medicare Denominator Files for the years 2001 to 2004. Using the Social Security Death Index, we identified all “late”
deaths, defined as deaths occurring >30 days and after hospital discharge. We used the National Death Index to identify
cause of death information; in particular, those deaths that were likely caused by late rupture. We compared causes of late
death and survival between EVAR and open repair using Wilcoxon log-rank and rank-sum tests.
Results: Between 2001 and 2004, 13,971 patients underwent AAA repair (6119 EVAR, 7852 open repair). After a mean
follow-up of 1.6 years in the EVAR cohort and 1.9 years in the open cohort, mortality rates were similar across repair type
(15.4% EVAR, 15.9% open repair), with an adjusted odds ratio for death after open repair of 0.98 (95% confidence interval,
0.90-1.07). Of the 2194 documented deaths, 523 occurred before discharge or <30 days, and 1671 occurred >30 days
and after hospital discharge. Cause of death information for the 1671 late deaths was available from the National Death
Index for 1515 (91%). The 15most common codes for causes of late death were dominated by cardiac disease (atherosclerotic
heart disease, acute myocardial infarction) and pulmonary disease (lung cancer, respiratory failure). Causes of late death with
specificmention of aneurysmwere identified in 37 patients (2.4% of all deaths), but this event was notmore common in EVAR
or open repair (15 [0.3%] in the EVAR group, 22 [0.3%], in the open repair group; P  .71).
Conclusions: Late deaths from aneurysm rupture after EVAR or open repair appear to be relatively infrequent and
similarly distributed across procedure type. Our results emphasize that the effectiveness of EVAR is comparable to open
AAA repair in preventing aneurysm-related death. (J Vasc Surg 2010;51:1340-7.)Several controlled trials and national cohort studies
have demonstrated lower perioperative morbidity andmor-
tality with endovascular abdominal aortic aneurysm (AAA)
repair (EVAR) compared with open repair.1-6 However,
regardless of the technique of repair, operative treatment of
an AAA does not completely ensure that a patient will
remain free from aneurysm-related morbidity or mortality
for the rest of his or her life.7-9 For example, patients who
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1340undergo open repair can experience graft-related complica-
tions, such as the development of a pseudoaneurysm or
latent graft infection.8
Similarly, along with significant device costs4,10 and the
need for extended follow-up and serial imaging,11,12 pa-
tients who undergo EVAR often have endoleaks, which
occur when the stent graft fails to exclude blood flow from
the aneurysm sac.12-14 Although pseudoaneurysm or infec-
tion after open repair is relatively uncommon, endoleaks
occur in 5% to 10% of all EVARs and have been associated
with late rupture of AAAs in several reports.1,15-17 The
relative frequency of EVAR-related complications, such as
endoleaks, and lack of survival difference between patients
undergoing EVAR and open repair have caused many to
question if the potential benefits of the less-invasive proce-
dure are outweighed by excess late deaths caused by de-
layed procedural complications.16-18
To further characterize late deaths occurring after
EVAR and open AAA repair, we therefore examined
patients undergoing infrarenal AAA repair in the Medi-
care population and compared short-term (combined
in-hospital and 30 day) and long-term mortality rates
with EVAR and open repair. Then, using death records
obtained from the National Death Index (NDI), we
compared causes of late death after EVAR and open
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to late aneurysm rupture.
METHODS
The Institutional Review Board at Dartmouth Medical
School reviewed and approved our study protocol.
Databases and exclusion criteria. We studied all pa-
tients undergoing infrarenal AAA repair in the Medicare
population for this analysis. Using the Medicare Part A
(MedPAR) files, a 20% random sample of physician claim
files (Part B), and the Medicare Denominator Files for the
years 2001 to 2004, we examined occurrences of AAA
repair codes (Appendix A, online only).19 These records
each contained a patient identifier, a Current Procedural
Terminology (CPT) procedure code and procedure date,
and up to 10 diagnosis codes from the International Clas-
sification of Diseases (ICD), 9th Clinical Modification.
Our unit of analysis in this study was the patient. We
used CPT codes (Appendices A and B, online only) to
identify the procedure as open or endovascular. If a patient
had more than one AAA procedure code, we counted only
the initial event and assigned the patient to that type of
repair (EVAR or open repair). We assumed that the first
procedure was endovascular if both an open and an endo-
vascular procedure occurred in the same patient on the
same day.
We excluded suprarenal repairs, any event with a pro-
cedure code that indicated repair of a ruptured aortic
aneurysm, and any event with a procedure code for a
thoracic aortic aneurysm repair. We excluded claims that
did not contain a diagnosis code for nonruptured AAA and
those patients whose repairs had a concurrent diagnosis
code of AAA rupture. Lastly, we excluded patients eligible
for Medicare for reasons other than age (eg, disability),
managed care enrollees, and patients not assigned to Medi-
care Part A and Part B at the time of the index procedure.
We then used the CPT codes, shown in Appendix A (online
only), for each event and characterized the procedure as
open or endovascular.
Determination of patient characteristics. Next, we
used theMedPAR file (Part A file) and the denominator file
to ascertain demographic characteristics of each patient
(date of birth, sex, race, and date of death) and patient-level
comorbidities. Comorbidities were identified according to
the Dartmouth-Manitoba claims-based modification of the
Charlson comorbidity index,20,21 Using the comorbidities
listed in Table I,we evaluated for the presence of cardiac or
cerebrovascular disease, diabetes, pulmonary disease, can-
cer, renal insufficiency, dementia, and immunologic dis-
ease.
Main outcome measures and analysis. Our study
had three main outcome measures: short-term mortality,
long-term mortality, and cause of death. Short-term mor-
tality was defined as death occurring within the index
hospital stay or30 days of the procedure date. Long-term
mortality was defined as death occurring after discharge
and 30 days; we termed these events “late” deaths.To determine cause of death, we used information
contained in the NDI, a central computerized index of
death record information maintained by the National Cen-
ter for Health Statistics. Using the patient’s Social Security
number, Medicare HIC identifiers, and age and gender
identifiers, we matched late deaths identified in the Medi-
care denominator (eligibility) file and the NDI. This was
accurately accomplished in 1515 of 1671 deaths (91%) in
our cohort (Fig 1).
Once deaths were matched, causes of death were ob-
tained from the NDI22 and compared between EVAR and
open repair. The NDI determines the underlying cause of
death by using data obtained from death certificates. Death
certificates require the provider to describe the immediate
cause of death and subsequently list up to four conditions
that contributed toward the underlying cause of death.
Other significant conditions that contributed to death (but
did not result in the underlying cause of death) are also
recorded. For this analysis, we used the ICD-10 code for
the underlying cause of death.
We selected ICD-10 codes that explicitly stated the
word “aneurysm” in the cause of death and then compared
Table I. Patient characteristics of the endovascular and
open repair cohorts
Variable
EVAR
(n  6119)
No. (%)
Open repair
(n  7852)
No. (%) P value
Age
65-69 847 (13.8) 1378 (17.6) .0001
70-74 1556 (25.4) 2315 (29.5)
75-79 1792 (29.3) 2361 (30.1)
80-84 1317 (21.5) 1385 (17.6)
85 607 (9.9) 413 (5.3)
Male 5110 (83.5) 6016 (76.6) .0001
Race
White 5859 (95.8) 7496 (95.5) .18
Black 158 (2.6) 192 (2.5)
Other/unknown 102 (1.7) 2164 (2.1)
Comorbidities
Vascular disease 6119 (100.0) 7852 (100.0) NA
Myocardial infarction 1002 (16.4) 980 (12.5) .0001
Congestive heart failure 351 (5.7) 284 (3.6) .0001
Cerebrovascular disease 217 (3.6) 308 (3.9) .25
Paralysis 8 (0.1) 18 (0.2) .18
Mild diabetes 844 (13.8) 818 (10.4) .0001
Severe diabetes 75 (1.2) 59 (0.8) .004
COPD 2073 (33.9) 3040 (38.7) .0001
Cancer 631 (10.3) 585 (7.5) .0001
Metastatic cancer 50 (0.8) 54 (0.7) .38
Mild liver disease 23 (0.4) 23 (0.3) .4
Severe liver disease 11 (0.2) 9 (0.1) .31
Renal disease 127 (2.1) 189 (2.4) .19
Dementia 62 (1.0) 55 (0.7) .04
Ulcer 56 (0.9) 54 (0.7) .13
Rheumatologic disease 94 (1.5) 105 (1.3) .32
AIDS 1 (0.0) 1 (0.0) .86
AIDS, Acquired immunodeficiency syndrome; COPD, chronic obstructive
pulmonary disease; EVAR, endovascular aneurysm repair; NA, not
applicable.the incidence of these causes of death in the cohorts under-
JOURNAL OF VASCULAR SURGERY
June 20101342 Goodney et algoing EVAR vs open repair. Because “aneurysm” appears
in a variety of ICD-10 codes, we categorized the relation-
ship of the aneurysm to the mode of death. These descrip-
tions were graded by level of suspicion (high, moderate, or
low), with highest suspicion indicating that the cause of
death was most likely to represent a late rupture of an
infrarenal aortic aneurysm after repair. The comparison of
interest in this study was the cause of late mortality after
endovascular vs open repair. We described and compared
causes of death in the two groups using proportions. Sur-
vival analyses of patients whose causes of death were
deemed likely to be aneurysm-related were conducted us-
ing Wilcoxon log-rank and rank-sum tests, censoring those
who were lost to follow-up or died of causes that could not
be attributed directly to an AAA.
RESULTS
Patient characteristics. We studied 6119 Medicare
beneficiaries who underwent EVAR and 7852 patients who
underwent open repair between 2001 and 2004 (Table I).
Patients undergoing EVAR were slightly older (31%
aged 80 years for EVAR vs 23% for open repair, P 
.0001) and more likely to be male (85% EVAR; 77% open
repair; P  .0001). Patients undergoing EVAR had higher
rates of preoperative myocardial infarction (16% EVAR,
13% open repair; P  .0001) and congestive heart failure
(6% EVAR, 4% open repair; P  .0001). However, 34% of
patients undergoing EVAR carried a diagnosis of chronic
obstructive pulmonary disease vs 39% in open patients (P
.0001). Although other differences may have been statisti-
cally significant because of our large sample size, few other
clinically relevant differences were evident between the two
cohorts.
Short-term and long-term mortality. Short-term
mortality, a combined measure of in-hospital or 30-day
mortality, was 1.8% in patients undergoing EVAR and 5.3%
Fig 1. Construction of the open and endovascular co
National Death Index.in open repair (crude odds ratio [OR], 0.33; 95% confi-dence interval [CI], 0.27-0.41, P .0001). Adjustment for
patient characteristics had little effect on the risk of death
for patients undergoing EVAR (risk-adjusted OR, 0.31;
95% CI, 0.25-0.38; P  .0001).
Overall long-term mortality was similar in both
cohorts—15.3% for EVAR and 15.9% for open repair—at a
median follow-up of 1.6 and 1.9 years, respectively, with an
adjusted hazard ratio for mortality for patients undergoing
endovascular repair of 0.98 (95% CI, 0.90-1.07). EVAR
conferred no significant survival advantage compared with
open repair (Fig 2 and Table II). As expected, Fig 2
demonstrates the likelihood of early mortality to occur in
patients undergoing open repair. Deaths in patients under-
going EVAR occurred later, with the two curves crossing at
approximately 1.6 years of follow-up. The differences in
long-term mortality between EVAR and open repair were
not statistically significant, either unadjusted (OR for
EVAR, 1.07; 95% CI, 0.99-1.17; P  .05) or when ad-
justed for patient comorbidities (adjusted OR for EVAR,
0.98; 95% CI, 0.90-1.07; P  .05).
Causes of late death. We identified 2194 deaths,
comprising 944 deaths among 6119 EVAR patients and
1250 deaths among 7852 open repair patients. Of these
deaths, 523 (111 EVAR, 412 open repair) occurred before
discharge or 30 days. The remaining 1671 deaths oc-
curred30 days and were termed “late deaths.” Using the
NDI, we were able to identify the underlying cause of death
in 1515 patients (91%).
We limited the following analyses to the cohort of
patients who survived the perioperative period and were
successfully matched with the NDI. In the EVAR cohort of
5509 patients, we studied 755 deaths that occurred within
a mean of 1.7 years (range, 0-3.6 years) of follow-up per
patient. Within the open surgery cohort of 6746 patients,
we studied 760 deaths that occurred within a mean of 2.0
for analysis. AAA, Abdominal aortic aneurysm; NDI,hortsyears (range 0-3.6 years) of follow-up per patient.
aneu
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ICD-10 codes indicating the cause of death. The 15 most
common codes for causes of late death in this cohort are
listed in Table III. These deaths represent 58% of all deaths
in the cohort and are dominated by ischemic heart disease
(18%), lung cancer (13%), and pulmonary disease (6%).
Aneurysm-related late deaths. AAA without men-
tion of rupture (ICD-10 I714) was the 14th most common
cause of death (24 patients, 1.6% of all deaths studied,
Table III). However, aortic aneurysm appears in a variety of
other cause-of-death descriptions. These descriptions were
graded by level of suspicion (high, moderate, or low), with
highest suspicion indicating that the cause of death was
most likely to represent a late rupture of an infrarenal aortic
aneurysm after repair. For example, two patients (0.1% of all
deaths) died with cause of death listed as ruptured AAA
(ICD-10 I713); this was listed in the “highest level of suspi-
cion” category (Table IV). In contrast, in the “lowest level of
suspicion” category, one patient died with a cause of death
listed as rupture of a thoracic aortic aneurysm (ICD-10 I711).
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Fig 2. Survival after abdominal aortic
Table II. Mortality after endovascular and open repair
Variable
AAA repair
Open Endovascular
Cases, No. 7852 6119
Follow-up, y 1.9 1.6
Total deaths, No. 1250 944
Death rate,a % 15.9 15.4
AAA, Abdominal aortic aneurysm.
aCrude hazard ratio, 1.07 (95% confidence interval, 0.99-1.17); adjusted
hazard ratio, 0.98 (95% confidence interval, 0.90-1.07).In all, we identified 40 aneurysm-related late deaths (2.6% ofall deaths); of which 26 were high suspicion, 11 were moder-
ate suspicion, and 3 were low suspicion.
Aneurysm-related late deaths by type of aneurysm
repair. We studied the effect of the type of aneurysm repair
(EVAR vs open repair) on the incidence of aneurysm-
related late deaths. As reported in Table V, the causes of
aneurysm-related late deaths were similar across EVAR and
open repair. Overall, the number of deaths related to an
aortic aneurysm was low in both cohorts, and no statistical
differences existed across categories of high, moderate, and
low suspicion of cause of death. In summary, late death due to
AAA rupture was rare andwas notmore common in EVAR vs
open repair, occurring in 15 patients (0.3%) in the EVAR
group and in 22 (0.3%), in the open repair group (P .71).
Last, we compared the timing of late deaths among
patients whose late deaths were aneurysm-related. In this
analysis, we defined “aneurysm-related” as any death coded
with a “high suspicion” or “moderate suspicion” ICD-10
code and censored individuals who died of other causes or
were lost to follow-up. Of the 37 deaths that were high or
moderate suspicion, survival of patients experiencing late
aneurysm-related deaths was similar between those under-
going EVAR and open repair (log-rank P  .86). The
distribution of times of death is reported in Table VI. These
differences are small in magnitude and are not statistically
significant.
DISCUSSION
The goal in the treatment of AAA is to provide protec-
tion from aneurysm rupture, because untreated rupture is
almost always fatal, and repair in the setting of rupture
poses a significantly higher risk for open than for elective
repair.8 Before 1996, open repair was the only surgical
option for prevention of rupture. Although it is invasive
670 731 790 851 912 974 1035 1096 1155 1216 1277 1339 1400
fter AAA Repair
vival Endo AAA Repair Survival
rysm (AAA) repair by procedure type.7 609
ays A
pair Surand morbid, open AAA repair is effective in preventing
eases.
eases;
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open repair.7 After 1996, EVAR emerged as an alternative
treatment for infrarenal AAA.13 However, the need for
repeat intervention after EVAR is common, and there
are numerous reports of late aneurysm rupture after
EVAR.14,23,24
These two facts have led many to express concerns
about the long-term efficacy of EVAR in preventing aneu-
rysm rupture and aneurysm-related death.4,18 However,
Table III. Fifteen most common ICD-10 codes indicatin
underwent aortic aneurysm repair
ICD-10 code Freq (% of total) Ca
C349 198 (13.0) Neopl
I251 152 (10.0) Ischem
I219 114 (7.5) Ischem
J449 94 (6.2) Respir
I64 41 (2.7) Cereb
J189 36 (2.4) Respir
I250 32 (2.1) Ischem
C61 30 (2.0) Neopl
I500 26 (1.7) Heart
A419 24 (1.6) Infecti
C679 26 (1.7) Neopl
C80 26 (1.7) Neopl
I619 25 (1.7) Cereb
I714 24 (1.6) Vascul
J439 24 (1.6) Respir
AAA, Abdominal aortic aneurysm; ICD, International Classification of Dis
Table IV. Eight ICD-10 codes indicating cause of death
enrollees who underwent aortic aneurysm repair
ICD-10 code Freq. (% of total) Cate
High suspicion
I713 2 (0.1) Vasc
I714 24 (1.6) Vasc
Moderate suspicion
I718 2 (0.1) Vasc
I719 5 (0.3) Vasc
I729 4 (0.3) Vasc
Low suspicion
I711 1 (0.1) Vasc
I712 1 (0.1) Vasc
I716 1 (0.1) Vasc
AAA, Abdominal aortic aneurysm; ICD, International Classification of Dis
Table V. Causes of late death by level of suspicion for
aneurysm-related cause of death and procedure type
Level of suspicion
EVAR Open repair
(n  755 deaths) (n  760 deaths)
No. (% of all deaths) No. (% of all deaths)
None 739 (97.9) 736 (96.8)
Low 1 (0.1) 2 (0.3)
Moderate 4 (0.5) 7 (0.9)
High 11 (1.5) 15 (2.0)our national analysis of death certificate informationfrom 12,000 patients who underwent AAA repair re-
veals that late deaths from aneurysm rupture after AAA
repair are uncommon and occur at similar rates for open
repair and EVAR. These findings do not support evidence,
anecdotal or otherwise, for higher risks of late aneurysm
se of death in the cohort of Medicare enrollees who
y of death Detail
Bronchus or lung, unspecified
art disease Atherosclerotic heart disease
art disease Acute myocardial infarction
system
cular disease Stroke, unspecified
system
art disease Atherosclerotic cardiovascular disease
Prostate
se Congestive heart failure
Septicemia unspecified
Bladder, unspecified
Malignancy with no specified site
ular disease Intracerebral hemorrhage
ease AAA, without mention of rupture
system
d to an aortic aneurysm in the cohort of Medicare
f death Detail
isease AAA ruptured
isease AAA, without mention of rupture
isease AA of unspecified site, ruptured
isease AA of unspecified site, no mention of rupture
isease aneurysm of unspecified site
isease TAA rupture
isease TAA without mention of rupture
isease TAA, without mention of rupture
TAA, thoracic aortic aneurysm.
Table VI. Distribution of times of death among
abdominal aortic aneurysm repair patients who died of a
high or moderate suspicion cause, by procedure type
Time to death, d
Procedure type
EVAR Open repair
(n  15) (n  22)
31-60 0 5
61-90 3 2
91-120 1 3
121-180 3 3
181-365 4 1
366-730 1 3
730 3 5g cau
tegor
asm
ic he
ic he
atory
rovas
atory
ic he
asm
disea
on
asm
asm
rovasc
ar dis
atoryrelate
gory o
ular d
ular d
ular d
ular d
ular d
ular d
ular d
ular drupture-related mortality after EVAR.
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term follow-up studies of EVAR. For example, in the
Lifeline Registry of Endovascular Aneurysm Repair, 18
events categorized as “late ruptures” occurred within a
6-year follow-up period in 2664 EVAR patients.1 In this
registry designed to study the safety and efficacy of EVAR,
no late ruptures occurred among 334 matched controls
that underwent open repair. However, this difference in
late rupture rates did not result in a significant difference in
aneurysm-related deaths. In terms of aneurysm-related
death (defined as death from any cause 30 days of the
primary procedure, death 30 days of a secondary proce-
dure or surgical conversion, or death due to aneurysm
rupture or graft complication), no significant differences
were found at 1 year between EVAR and open repair
patients. The authors concluded that this established
EVAR as a safe, effective, and durable treatment for infra-
renal AAA.
Critics of this report note that 34% of the EVAR group
died during follow-up, with limited information on the
cause of death.18 In addition, they note a nearly 20% repeat
intervention rate was necessary to ensure efficacy of the
endografts in preventing rupture. In contrast, in a study of
long-term outcomes of a multicenter randomized trial of
EVAR vs open repair in the Netherlands, Blankensteijn et
al25 reported no late ruptures in either group at the 2-year
follow-up. Further, although their study demonstrated a
higher aneurysm-related death rate in those undergoing
open repair (5.7% vs 2.1%, P  .05), this difference in
aneurysm-related mortality was based entirely on the dif-
ference in in-hospital (perioperative) mortality; only one
late death occurred in each group.
Despite these reassurances from randomized trials in
high-volume centers of excellence in EVAR, many have
reported significant concerns about late rupture and
aneurysm-related death from EVAR.2,16,26 Stent graft
migration, loss of fixation, endoleaks, and stent fracture
have all been reported after EVAR, and each has been
linked to late rupture.27,28 In addition, late rupture has
occurred even in the absence of endoleak, likely related to
endotension, which is caused when porosity of the stent-
graft material transmits pressure into the aneurysm sac.29-31
Many wondered, as EVAR has become common in clinical
practice outside of randomized trials,5 if a rising incidence
of graft-related complications, coupled with less-than-ideal
follow-up, might result in a higher rate of late rupture and
aneurysm-related death in those patients undergoing
EVAR.32 Further, a recent national analysis of Medicare
patients undergoing AAA repair concluded that late
aneurysm rupture was more common in patients who
underwent EVAR than open repair (1.8% vs 0.5%, P 
.001), although no long-term survival differences were
noted between groups.5
The differing conclusions about the likelihood of late
aneurysm rupture found between our study and that report
may lie in the methodologic differences across the studies.
For example, Schermerhorn et al5 used a propensity score
to match similar patients who had undergone open repairand EVAR and monitored the cohort of matched patients
for 3 years.
First, our study did not use propensity scoring to
account for selection bias in the assignment of patients to
EVAR or open repair. Propensity matching has been well
described, but one of the weaknesses of this technique is
that propensity scores tend to overestimate treatment ef-
fects because of survivor bias—only those patients contrib-
uting to the risk prediction model are those that survived to
undergo treatment.33,34 Rather than propensity score
matching, we used logistic regression models using the
Dartmouth-Manitoba claims-based modification of the
Charlson comorbidity index. This methodology, although
limited in the extent of clinical precision, has been validated
broadly in surgical and nonsurgical settings.20,21,35 Further, it
is important to note that regardless of risk-adjustment tech-
niques, little published evidence suggests that patients differ
dramatically across treatment groups, especially in a large,
national analysis.36,37
Second, in the prior studies of late aneurysm rupture in
Medicare patients, late aneurysm rupture was defined using
ICD-9 codes rather than ICD-10 death certificate informa-
tion, whichmay have contributed further to differences in
our findings. We did not have access to the incidence of
autopsy confirmation of the cause of death in our study,
and therefore it is possible—and some may argue likely—
that our study produced a low estimate of late deaths
related to AAA repair.
Could our study have missed a higher rate of late
rupture or aneurysm-related death in patients who have
undergone EVAR? Although this is possible for several
reasons, we believe this is unlikely:
First, the limitations of death certificates in determining
the cause of death have been well described22,38 when used
in combination with administrative identifiers such as Social
Security records and ICD-9 codes, but the NDI has been
found to be 97% sensitive and 99% specific in identifying
known deaths.22
Second, studies comparing known causes of death from
a direct information source with causes of death registered
in the NDI have found a discrepancy of less than 4%
between the two records.22,39
Finally, because late aneurysm-related death or rupture
can occur in patients undergoing EVAR or open repair,
there is little reason to believe that errors in assignment of
cause of death would vary systematically by the type of
aneurysm repair. However, we recognize that deaths due to
aneurysm rupture often present clinically as sudden death
and may be attributed to other causes (eg, myocardial
infarction). This may result in undercoding of aneurysm-
related death, regardless of repair type,22,40,41 given that a
patient may not undergo autopsy to rule out aneurysm-
related causes of death.
Our study has several other limitations. The patient
characteristics in our groups were similar; however, certain
key variables important in determining outcome after AAA
repair, such as aneurysm diameter and precise location, are
not available in administrative data,2,42 and it is therefore
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founded our outcome measures. However, any bias intro-
duced by differences in aneurysm size or complexity would
tend to favor EVAR because large aneurysm size has been
directly associated with late rupture,2 and patients with
more complex anatomy are more likely to have received
open repair.43
Second, coding errors other than those that have been
described have occurred. However, the use of both Medi-
care Part A and Part B, as well as Social Security and NDI
information, make systematic administrative errors in either
EVAR or open repair unlikely.
Third, our definition of aneurysm-related death was
more stringent than what was used in the Lifeline registry.
Their end point of aneurysm-related death included not
only deaths after aneurysm rupture but also all periopera-
tive deaths that occurred within the first 30 days after
surgery as well as within the first 30 days after any secondary
intervention. Given that our interest was in examining the
effectiveness of EVAR in preventing aneurysm-related
death, we studied that end point specifically rather than a
broader outcome that would capture perioperative events
from secondary procedures occurring in the early postop-
erative period.
Further, our study, as well as others,5,25 found that
most aneurysm-related deaths not caused by rupture in-
volve perioperative mortality from the initial AAA repair,
regardless of procedure type. Therefore, it is unlikely our
findings would change significantly by including perioper-
ative events after secondary procedures because of the
lower incidence of morbidity and mortality after secondary
procedures relative to the incident AAA repair.
Finally, our data set was expansive but was limited by a
relative short mean follow-up of just less than 2 years.
Although traditional end points of aneurysm-related death
classify late deaths as those occurring 30 days,7,9 these
events may be better termed “midterm” death after AAA
repair. Future postmarket surveillance efforts aimed at
combining clinical registries and administrative data sets
will attempt to establish longer follow-up of these large
cohorts of patients to discern if differences emerge in the
underlying cause of death over time.
CONCLUSIONS
Our analysis of outcomes in the real world of Medicare
patients suggests that despite a relatively common need for
secondary interventions, the midterm (and arguably long-
term) effectiveness of EVAR in preventing aneurysm-
related death is similar to open repair. Patients and
surgeons should expect similar protection from aneurysm-
related death from both open and endovascular AAA repair
as long as patients are selected appropriately preoperatively
and close surveillance is used postoperatively.
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June 20101347.e1 Goodney et alAppendix A (online only). Procedure and diagnosis
codes used to identify the cohort
CPT codes
To identify open infrarenal AAA repairs:
35081 Direct repair of AAA
35102 Direct repair of AAA involving iliac vessels
To identify endovascular AAA repairs:
34800 Endovascular AAA exclusion with tube graft
34802 Endovascular AAA exclusion with bifurcated modular
graft
34803 Endovascular AAA exclusion with bifurcated
prosthesis
34804 Endovascular AAA exclusion with bifurcated unibody
prosthesis
34805 Endovascular AAA exclusion with aortouniiliac or
aortounifemoral graft
Exclusions – ruptured or suprarenal aneurysm repairs:
35091 Direct repair of AAA involving visceral vessels
(suprarenal)
35697 Reimplantation of visceral arteries to aortic prosthesis
35082 Direct repair of AAA, ruptured
35092 Direct repair of AAA involving visceral vessels
(suprarenal), ruptured
35103 Direct repair of AAA involving iliac vessels, ruptured
33877 Repair of thoracoabdominal aortic aneurysm with
graft
ICD-9 diagnosis codes
To identify nonruptured AAAs:
441.4 Abdominal aortic aneurysm, not ruptured
Exclusions – ruptured or suprarenal aneurysms
441.3 Abdominal aortic aneurysm, not ruptured
441.6 Thoracoabdominal aneurysm, ruptured (exclude)
441.7 Thoracoabdominal aneurysm, not ruptured (exclude)
AAA, Abdominal aortic aneurysm; CPT, Current Procedural Terminology;
ICD, International Classification of Diseases.Appendix B (online only).Details of Medicare claims files
used in our analysis
Medicare files available for
analysis Details
Medicare Provider Analysis
and Review (MEDPAR)
Files (Part A)
Data on inpatient hospitalizations
for Medicare beneficiaries
under the hospital insurance
Part A program. This contains
all inpatient hospitalizations
and provided hospitalization
characteristics, such as urgency
of admission, length of stay,
etc.
Carrier Standard Analytic
Files (SAF)
(“Part B”):
Data on services provided by
physicians and other non-
institutional providers for
Medicare beneficiaries. We
used 20% national samples to
identify the procedures using
CPT codes and construct the
analytic cohort.
Denominator files This file contains demographic
and enrollment information on
Medicare beneficiaries, indexed
by year, and provides risk-
stratification information for
our analysis.
Hierarchical condition
categories (HCCs):
Used for risk adjustment in
Medicare coding and
reimbursement, these are
groupings of ICD-9 diagnoses
that have been used in prior
studies of cardiovascular
disease.
CPT,Current Procedural Terminology; ICD, International Classification of
Diseases.
